Literature DB >> 17684349

Online hemodiafiltration. Technical options and best clinical practices.

B Canaud1.   

Abstract

Online production of substitution fluid by 'cold sterilization' (ultrafiltration) of dialysis fluid gives access to virtually unlimited amounts of sterile and nonpyrogenic solution. The incorporation of the online hemodiafiltration (ol-HDF) module into the dialysis proportioning machine hardware simplifies the handling procedure, secures the process by keeping the safety regulation of the monitor and offers virtually unlimited amounts of sterile and nonpyrogenic substitutive solution. The safety of the ol-HDF relies upon use of ultrapure water and strict and permanent highly hygienic rules of use. The use of a specifically designed certified HDF machine is also mandatory. Several forms of ol-HDF have been developed and used to cover specific clinical needs of chronic kidney disease patients. Conventional ol-HDF are classified according to the mode of substitution as post-, pre- and mixed dilution. Alternative-based ol-HDF incorporate push/pull HDF, double high-flux HDF, paired HDF and middilution HDF. A very simple description of these methods is provided in this section. Best clinical practices are summarized in this section to optimize performances of ol-HDF and maximize the safety of the method. It is noteworthy to stress the important role of blood flow, fluid volume exchange, hemodiafilter performances and duration of sessions in the overall treatment efficacy. It is also crucial to insist on the importance of strict hygienic handling, microbiology monitoring and the quality assurance process to ensure the safety of the method. In addition, ol-HDF offers the best technical platform to develop new therapeutic strategies such as daily treatment, total automation of priming and cleansing procedures and biofeedback volume control.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17684349     DOI: 10.1159/000107241

Source DB:  PubMed          Journal:  Contrib Nephrol        ISSN: 0302-5144            Impact factor:   1.580


  7 in total

Review 1.  Choices in hemodialysis therapies: variants, personalized therapy and application of evidence-based medicine.

Authors:  Bernard Canaud; Stefano Stuard; Frank Laukhuf; Grace Yan; Maria Ines Gomez Canabal; Paik Seong Lim; Michael A Kraus
Journal:  Clin Kidney J       Date:  2021-12-27

2.  Online hemodiafilteration use in children: a single center experience with a twist.

Authors:  Magid A A Ibrahim; Ihab Z ElHakim; Dina Soliman; Muhammad A Mubarak; Ragia M Said
Journal:  BMC Nephrol       Date:  2020-07-28       Impact factor: 2.388

3.  Efficacy of enoxaparin in preventing coagulation during high-flux haemodialysis, expanded haemodialysis and haemodiafiltration.

Authors:  Alba Santos; Nicolás Macías; Almudena Vega; Soraya Abad; Tania Linares; Inés Aragoncillo; Leonidas Cruzado; Cristina Pascual; Marian Goicoechea; Juan Manuel López-Gómez
Journal:  Clin Kidney J       Date:  2020-06-22

Review 4.  Informed decision-making in delivery of dialysis: combining clinical outcomes with sustainability.

Authors:  Christian Apel; Carsten Hornig; Frank W Maddux; Terry Ketchersid; Julianna Yeung; Adrian Guinsburg
Journal:  Clin Kidney J       Date:  2021-12-27

Review 5.  Advanced hemodialysis equipment for more eco-friendly dialysis.

Authors:  Adelheid Gauly; Nicole Fleck; Fatih Kircelli
Journal:  Int Urol Nephrol       Date:  2021-09-04       Impact factor: 2.370

6.  Prescribing Hemodialysis or Hemodiafiltration: When One Size Does Not Fit All the Proposal of a Personalized Approach Based on Comorbidity and Nutritional Status.

Authors:  Giorgina Barbara Piccoli; Louise Nielsen; Lurilyn Gendrot; Antioco Fois; Emanuela Cataldo; Gianfranca Cabiddu
Journal:  J Clin Med       Date:  2018-10-08       Impact factor: 4.241

7.  Randomised trial on clinical performances and biocompatibility of four high-flux hemodialyzers in two mode treatments: hemodialysis vs post dilution hemodiafiltration.

Authors:  Marion Morena; Caroline Creput; Mouloud Bouzernidj; Annie Rodriguez; Lotfi Chalabi; Bruno Seigneuric; Céline Lauret; Anne-Sophie Bargnoux; Anne-Marie Dupuy; Jean-Paul Cristol
Journal:  Sci Rep       Date:  2019-12-04       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.